The Hidden Market for Nervous System Support
Building Infrastructure for an Underserved Consumer Market
L.C. Grass
Founder, TenderVerse™
April 2026
ABSTRACT
This paper examines a large, under-recognized consumer and care market focused on nervous system regulation and emotional intelligence.
Six years after COVID‑19, the evidence points to a widening gap between population‑level stress and the systems designed to respond to it. Current research suggests that burnout, chronic stress, and post‑pandemic nervous system dysregulation are affecting a large and often invisible group of people, including employed adults, caregivers, children, and people living with Long COVID and other chronic health challenges or limitations. Traditional healthcare systems are not structured to address this full spectrum of need and, as such, are leaving a substantial gap in accessible support.
This is not only a healthcare challenge; it also appears to be a major market failure.
Research indicates that the disability community and its broader support network represent roughly $13 trillion in annual spending power, while the same research suggests that only 2% of disabled consumers feel accurately represented in media, products, and services and 50% report barriers to accessing content and products. Yet 54% report being more likely to favor companies that represent disability authentically.
This paper uses that representation gap to argue for an even broader category of underserved users, including children with mental health disorders and older adults reporting mental health conditions, substance use disorders, or both.
Drawing on peer‑reviewed research from the World Health Organization, Nature Communications, and related sources, along with market research from the Valuable 500, this paper proposes a new category: nervous system infrastructure.
It argues that accessible, low‑friction regulation support is a missing layer in both health and consumer markets and it outlines TenderVerse™ as an early product concept in that category.
Note
Section 1: The Burnout to Disability Pipeline
This paper makes three arguments:
First, chronic stress has become a population‑scale public health issue with documented physiological and economic consequences.
Second, the populations most at‑risk of being additionally negatively affected by this issue represent a large and underserved consumer market.
Third, TenderVerse™ is being developed as a product and distribution layer designed to meet that gap.
What follows is the evidence for each claim.
1.1 The Prevalence: How Many People We Are Talking About
In February 2025, research conducted by Moodle in partnership with Censuswide found that 66% of American employees reported experiencing burnout, an all‑time high (Robinson, 2025). Among workers aged 25 to 34, the figure was 83%. These workers entered or advanced in their careers during and after the COVID‑19 period, which makes the trend especially important for long‑term workforce planning.
Earlier data from the National Alliance on Mental Illness (2024) found that 52% of employees reported feeling burned out because of their job in the past year, with women and younger workers reporting higher rates than men and older workers overall. A 2025 summary by HIGH5 Test further notes that 59% of women and 46% of men reported feeling burned out in 2024. The scale of these findings suggests a widespread workforce health issue rather than a short‑lived trend.
1.2 The Cost & What This Is Doing to Us Physically and Economically
In 2015, Joel Goh, Jeffrey Pfeffer, and Stefanos Zenios published a landmark study in Management Science estimating the aggregate health and economic impact of workplace stressors in the United States (Goh et al., 2015).
The World Health Organization codified burnout in the International Classification of Diseases in 2019, defining it as an occupational phenomenon resulting from chronic workplace stress that has not been successfully managed, and characterized by energy depletion, increased mental distance from one's job, and reduced professional efficacy (WHO, 2019). That classification supports treating burnout as a legitimate health issue rather than a vague feeling.
1.3 Beyond the Workplace: Six Years of Collective Stress
Burnout is not limited to workplace conditions. In 2025, the top reported stressors driving burnout included U.S. politics, global events, and personal finances, suggesting that many of the pressures shaping burnout are not strictly occupational (Mind Share Partners, 2025, as summarized in HIGH5 Test, 2025). Six years after the onset of COVID‑19, the conditions shaping work and daily life are not the same as they were in 2019.
Burnout should be understood less as an individual failing than as a response to sustained pressure across multiple domains of life. The more important question is not whether the problem exists, but what kinds of support systems are actually capable of addressing it at scale.
References
Goh, J., Pfeffer, J., & Zenios, S. A. (2015). The relationship between workplace stressors and mortality and health costs in the United States. Management Science, 62(2), 608–628. https://doi.org/10.1287/mnsc.2014.2115
HIGH5 Test. (2025, October 9). 15+ employee burnout statistics in the workplace. https://high5test.com/employee-burnout-statistics/
National Alliance on Mental Illness. (2024). NAMI workplace mental health poll 2024. https://www.nami.org/wp-content/uploads/2024/03/NAMI-Workplace-Mental-Health-Poll-2024.pdf
Robinson, B. (2025, February 8). Job burnout at 66% in 2025, new study shows. Forbes. https://www.forbes.com/sites/bryanrobinson/2025/02/08/job-burnout-at-66-in-2025-new-study-shows/
World Health Organization. (2019). QD85 burnout. In International statistical classification of diseases and related health problems (11th ed.). https://icd.who.int/browse11/l-m/en
Section 2: The Economic Reality
Section 1 established burnout as a public health issue. This section reframes that issue as a market reality: a large and underserved population needs accessible nervous system support, but current wellness and care systems are not designed around that need. The people most affected by chronic stress, burnout, and nervous system dysregulation are not a niche. This paper argues they represent one of the largest and most underserved consumer populations in the world.
That ordering is intentional. The public health failure and the market failure are not separate stories; they are the same story. Naming the market gap first makes clear that what follows is not only an argument for compassion, but an argument for infrastructure.
2.1 The Population: Who We Are Actually Talking About
The World Health Organization estimates that over 1.3 billion people, or roughly 15 to 20% of the global population, experience some form of disability (World Economic Forum, 2023). This estimate is based on pre‑pandemic data. The population this paper describes is not a single, fixed demographic.
It is a spectrum: the burned‑out worker who cannot explain why nothing feels right anymore, the Long COVID survivor operating at a fraction of previous capacity, the parent trying to establish a bedtime routine for a child who cannot wind down, the recently divorced or otherwise grieving, and the caregiver who has stopped tending to their own needs.
The population TenderVerse™ serves spans three overlapping groups: people with burnout, chronic disease or illness like Long COVID, and children and caregivers. The central overlap represents the population this paper calls "the other 98%." The broader point is that these groups are connected by a shared need for accessible, low‑friction nervous system support.
2.2 A Massive Market Gap
The disability community, together with friends and family, represents an estimated $13 trillion in combined global spending power, with roughly $8 trillion in direct disposable income (Valuable 500 et al., 2024). Put simply, this is not a niche market. It is one of the largest consumer segments in the world.
That scale matters because representation and access remain limited. Research from the Valuable 500, Yale University, and Open Inclusion state that only 2% of disabled consumers feel accurately represented in the products, services, and media available to them, and that more than half report barriers to access.
The result is a major gap between purchasing power and market design. In this paper, that gap is treated as an opportunity for products and systems built with accessibility, inclusion, and nervous system support at the center.
References
Consegi Business Intelligence. (2025). Mental wellness market size and share. https://www.consegi-businessintelligence.com/mental-wellness-market
McKinsey & Company. (2024). The trends defining the $1.8 trillion global wellness market in 2024. https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/
Perez, S. (2022, December 7). Calm is now valued at $2 billion. TechCrunch. https://techcrunch.com/2022/12/07/calm-valuation/
Precedence Research. (2025). Health and wellness market size to hit USD 11.61 trillion by 2035. https://www.precedenceresearch.com/health-and-wellness-market
Valuable 500, Open Inclusion, & Yale University. (2024, January). Nothing about us without us [White paper]. https://www.thevaluable500.com/
World Economic Forum. (2023, December). Driving disability inclusion is a business imperative. https://www.weforum.org/stories/2023/12/
Section 3: Six Years In & The Post‑COVID Nervous System
For a significant portion of the population, the pandemic did not end. Rather, it settled into the body. We now understand why the market gap in Section 2 is so large: the population that needs nervous system support the most has grown significantly since 2020, in ways that are only now becoming fully visible in the data.
3.1 What COVID‑19 Did to the Nervous System
COVID‑19 is now understood as a systemic disease with neurological and psychological effects. A 2025 systematic review and meta‑analysis published in Nature Communications, drawing on 50 studies totaling more than 14.6 million people, found increased risk of 39 out of 40 symptoms studied in individuals infected with SARS‑CoV‑2. The symptoms with the highest pooled relative risks were neurological and cognitive: loss of smell, poor concentration, and impaired memory (Nature Communications, 2025).
3.2 Long COVID: The Scale of What We Are Dealing With
The most current comprehensive synthesis comes from a 2025 meta‑analysis published in Open Forum Infectious Diseases, which drew on 429 studies and estimated global pooled Long COVID prevalence at 36% (Hou et al., 2025). A 2025 review in Nature Reviews Disease Primers placed the global affected population at between 80 and 400 million people.
3.3 The Mental Health Toll: A Crisis That Predated, Worsened, and Outlasted the Pandemic
A 2025 study published in Scientific Reports found that the weighted prevalence of depression among U.S. adults following the pandemic was 12.4%, significantly higher than in every survey cycle prior to 2020 (Scientific Reports, 2025). U.S. Census Bureau Household Pulse Survey data collected through April 2024 found that 21% of Americans were still reporting symptoms of anxiety or depression at roughly twice the pre‑pandemic rate.
Among children, the CDC's most recent data finds that 1 in 5 young people aged 3 to 17 experience a mental, emotional, or behavioral disorder (CDC, 2023).
The gap between what is demanded of people and what is physiologically possible is the crisis.
This is because many people are being asked to perform at pre‑pandemic levels while living with post‑pandemic physiological and cognitive burdens.
References
Centers for Disease Control and Prevention. (2023). Data and statistics on children's mental health. https://www.cdc.gov/childrensmentalhealth/data.html
Hou, Y., et al. (2025). Global prevalence of long COVID, its subtypes, and risk factors. Open Forum Infectious Diseases, 12(9). https://doi.org/10.1093/ofid/ofaf533
National Academies of Sciences, Engineering, and Medicine. (2024). A long COVID definition: A chronic, systemic disease state with profound consequences. The National Academies Press.
Nature Communications. (2025). The risk of long COVID symptoms: A systematic review and meta‑analysis. https://doi.org/10.1038/s41467-025-59012-w
Nature Reviews Disease Primers. (2025). COVID‑19‑associated neurological and psychological manifestations. https://doi.org/10.1038/s41572-025-00674-7
Scientific Reports. (2025). Influence of the COVID‑19 pandemic on the prevalence of depression in U.S. adults. https://doi.org/10.1038/s41598-025-87593-5
Section 4: When Stress Occurs in the Body
The stress response can treat psychological and physical threats as biologically salient and the body records the cost of repeated activation over time. Sections 2 and 3 established the populations and scale of what has happened since 2020. This section turns to physiology and examines how sustained stress can contribute to chronic illness and, in some cases, disability. The pipeline is grounded in biological mechanisms.
4.1 The Mechanism: What the Body Does With Stress It Cannot Resolve
When the body encounters a stressor, two primary systems activate in sequence. The sympathetic‑adrenal‑medullary (SAM) system triggers the immediate release of adrenaline and noradrenaline, producing the acute stress response. The hypothalamic‑pituitary‑adrenal (HPA) axis activates when the stressor persists. With sustained stress, HPA regulation can become disrupted, cortisol signaling can shift, inflammatory markers can rise, and immune and cognitive functioning can deteriorate (Shchaslyvyi et al., 2024; StatPearls / NCBI, 2024).
4.2 Allostatic Load: The Body's Running Tab
Allostatic load describes the cumulative physiological cost of adapting to stressors over time. It reflects wear and tear across the nervous, immune, cardiovascular, metabolic, and endocrine systems. Research links higher allostatic load with earlier chronic disease onset, accelerated aging, and higher mortality risk. Chronic stress does not remain isolated in one system; it can affect multiple body systems at once.
4.3 The Downstream Conditions: What the Pipeline Produces
A 2024 comprehensive review synthesizing over 200 studies documented links between sustained psychological stress and outcomes such as diabetes, cardiovascular disease, cancer, and immune dysregulation across multiple body systems (Shchaslyvyi et al., 2024). Conditions frequently discussed at the intersection of chronic stress, burnout, and immune dysregulation include MCAS, POTS, fibromyalgia, Long COVID, and cognitive decline, all of which disproportionately affect the population this paper describes.
4.4 Who Falls Through the Gap?
The American healthcare system is built for acute, diagnosable, billable conditions. It is less well‑designed to trace the relationship between years of workplace pressure, pandemic disruption, immune dysregulation, interpersonal or environmental stress, and the chronic conditions that may emerge later.
The people most affected are often mid‑career, often women, and often high‑functioning until they are not. Specialty‑based medical care can help, but access to those specialists remains limited.
4.5 The Founder's Perspective: Knowing More Than the Data Can Show
The founder of TenderVerse™ brings professional expertise in precision‑based content strategy and lived experience navigating the intersection of chronic illness, immune dysregulation, and a healthcare system not built to address either. Market data provides the validation. Her lived experience is the design asset and the very thing that ensures the solutions are built for how these conditions actually feel to live in, not just how they appear on a chart.
References
Felitti, V. J., et al. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. American Journal of Preventive Medicine, 14(4), 245–258. https://doi.org/10.1016
Section 5: Nervous System Support as the Missing Infrastructure
The body has innate regulatory capacity.
What many people lack is not capacity alone, but also the conditions that allow regulation to occur.
We have now established the population, the market gap, and the physiological pipeline that connects them. This section answers the solution question: what does the research say about accessible, scalable tools and education for nervous system regulation, and what does it suggest about how such regulation should be designed?
5.1 What Nervous System Regulation Actually Is
Nervous system regulation refers to the body's capacity to return to a state of physiological equilibrium after activation. In a well-regulated nervous system, the stress response activates and resolves flexibly.
In nervous systems that are dysregulated, that ability is compromised and the system can become stuck in chronic activation or in shutdown states that may look like depression, disconnection, or fatigue.
Regulation restores the nervous system's ability to move through states adaptively. The goal is flexibility, not flatness or reactivity.
5.2 The Evidence Base: What the Research Actually Shows
Somatic Experiencing (SE), developed by Peter Levine, targets the physiological underpinnings of trauma and chronic stress. A 2021 scoping literature review published in the European Journal of Psychotraumatology found preliminary evidence for positive effects of SE on PTSD-related symptoms (Kuhfuss et al., 2021). Heart rate variability (HRV) is one of the most widely used non-invasive biomarkers of autonomic nervous system function. A 2024 systematic review and meta-analysis found that stress-reducing interventions, including meditation, mindfulness, yoga, biofeedback, and CBT, produced significant beneficial effects on HRV parameters (MDPI, 2024). Breathwork interventions may also support parasympathetic activation, though the strength and consistency of effects vary by method and study design.
Georgia House Resolution 1007 (2026) formally acknowledged arts for health initiatives as clinically validated interventions for addressing symptoms of stress, trauma, and anxiety, citing the Kaiser Family Foundation's finding that 90% of Americans are facing increased mental health challenges. When a state legislature cites health research to validate arts-based nervous system support, that is not a fringe position. It reflects a growing institutional recognition that regulation support belongs in the broader health conversation.
5.3 The Polyvagal Question: Handled With Intellectual Honesty
No serious treatment of nervous system regulation in 2026 can ignore the polyvagal debate. In early 2026, a paper co-authored by 39 leading scientists declared Polyvagal Theory untenable. Porges published a rebuttal in the same journal issue (Porges, 2026; Grossman et al., 2026). This paper does not take a position in that debate. The clinical value of nervous system regulation practices does not depend on resolving that dispute. Somatic experiencing, breathwork, body-based grounding, and HRV-informed intervention all have evidence bases that predate and exist independently of polyvagal theory.
5.4 The Window of Tolerance: Why Meeting People Where They Are Matters
A dysregulated nervous system cannot easily engage with complex information, extended focused attention, or emotionally demanding material.
This is physiology, not a character flaw.
Accessible nervous system support must be designed for the actual window of tolerance of the people it is trying to reach.
Short. Gentle. Paced. Safe.
Delivered in formats that require little from the user beyond willingness to listen and connect. This is precision design for a specific physiological reality.
The question is not whether nervous system regulation can be helpful. The evidence suggests that it can. The more important question is whether it is designed for the people who need it most and whether those people can find it where they actually are.
References
Georgia House of Representatives. (2026). H.R. 1007: A resolution acknowledging the effectiveness of arts for health initiatives. 26 LC 112 3682. https://www.legis.ga.gov/api/legislation/document/20252026/239665
Grossman, P., et al. (2026). Why the polyvagal theory is untenable. Clinical Neuropsychiatry, 23(1).
Kuhfuss, M., et al. (2021). Somatic experiencing — effectiveness and key factors: A scoping literature review. European Journal of Psychotraumatology, 12(1), 1929023. https://doi.org/10.1080/20008198.2021.1929023
MDPI / Life. (2024). The effect of stress-reducing interventions on heart rate variability. 14(6), 749. https://doi.org/10.3390/life14060749
Porges, S. W. (2026). When a critique becomes untenable. Clinical Neuropsychiatry, 23(1).
van der Kolk, B. A. (2014). The body keeps the score. Viking.
Section 6: What TenderVerse™ Is & What It Is Not
TenderVerse™ is not a clinical intervention. It is not therapy. It does not diagnose, treat, or cure. It is not a meditation app optimized for people who already have time, space, and resources to spare.
TenderVerse™ is a brand and media universe grounded in inclusive design.
6.1 The Product Universe: Tools, Tales, and Toys
Its products — stories, tools, and objects — are designed from the ground up for the bodies and nervous systems that the existing wellness market was not built for. That includes the person in a Long COVID flare, the burned-out caregiver who cannot locate fifteen minutes of silence, the child who cannot wind down at bedtime, and the adult who never learned how to name what is happening in their body.
TenderVerse™ is not profiting from suffering. It is filling a gap that suffering has revealed — a gap the healthcare system cannot fill and the wellness industry has not. That distinction is built into the business model: free entry points, eventual library distribution, accessible price points, and products shaped through community listening rather than top-down invention. The business exists to make the infrastructure sustainable. The infrastructure exists to make support more accessible.
6.2 The Product Universe: Product Vision
TenderVerse Tales are somatic stories for children, inner children, and anyone who wants to end the day differently than they began it. They sit at the intersection of ASMR, somatic experiencing principles, and the deliberate rewriting of fairy tale narratives that have carried harmful messaging for generations. More than 50 stories are currently in draft. Two are live on YouTube. The near-term roadmap includes a black-screen YouTube channel publishing one story per week, followed by printed editions distributed through libraries, schools, and wellness partners.
TenderVerse Tools translate the science of Section 5 into physical and digital objects designed for real use in real bodies. Tools have been and will be developed through direct community research in the disability and chronic illness spaces. This way it's already where the people who need them already gather. Roadmap available upon request.
TenderVerse Toys include weighted objects that live inside the universe and range from stickers and coloring books to weighted plushies from the TenderVerse Tales. All designed for sensory regulation and emotional comfort. These are not simply decorative toys. They are story-based, somatically supportive objects.
6.3 The Distribution Strategy: Why Meeting People Where They Are Matters (aka Why Account-Based Marketing Works)
People in survival mode are not searching for "tools for nervous system regulation." They are searching for "relaxing bedtime stories." They are searching for "what to do waking up with panic attak", "calming down toddler tips", or "why can't I sleep" at 3:34am. They are searching for something calm.
TenderVerse™ finds them there.
The YouTube channel is the first point of contact and is free, accessible, and requiring nothing except willingness to listen. From there, the universe expands at whatever pace the user can sustain.
The primary customer is the burned-out working parent in the U.S. or Canada buying simultaneously for themselves and their child.
According to the U.S. Bureau of Labor Statistics, 32.7 million U.S. families included children under 18 in 2024, with at least one employed parent in 91.4% of them (BLS, 2025). In Canada, 47% of workers report burnout, with working parents at 51% (Robert Half Canada, 2025).
6.4 The Civilizational Frame: Why This Matters Beyond TenderVerse™
TenderVerse™ is not a cure for chronic stress. It is not a solution to the systemic conditions that produce burnout at population scale. What it is though, is infrastructure: the first iteration of a layer that does not currently exist. It is accessible nervous system support delivered via media content and physical resources, designed for the bodies that need it most, distributed in the places those bodies actually are.
In ten years, if TenderVerse™ works, children will have a language for their feelings earlier and the autonomy to use it. Adults will be more resourced, with more resilient nervous systems and greater capacity for presence.
And that presence, multiplied across millions of relationships, unlocks something the data does not fully capture yet: creativity, connection, and lives lived from the inside out rather than managed from the outside in.
The other 98% have been waiting long enough.
References
BLS. (2025). Employment characteristics of families — 2024. https://www.bls.gov/news.release/famee.nr0.htm
Grass, L. C. (2024). [Company redacted] enterprise demand generation performance data [Internal record, founder-verified].
Grass, L. C. (2024). [Company redacted] account-based marketing performance data [Internal record, founder-verified, corroborated by 6Sense platform reporting].
Robert Half Canada. (2025). Nearly half of Canadian workers feel burned out. https://press.roberthalf.ca/2025-03-25
TenderVerse. (2026). TenderVerse Tales [YouTube channel]. https://www.youtube.com/@Tender_Verse
United States Patent and Trademark Office. (2026). TenderVerse trademark applications [Pending; published in USPTO Official Gazette, March 2026].
Valuable 500, Open Inclusion, & Yale University. (2024, January). Nothing about us without us [White paper]. https://www.thevaluable500.com/